CVS Health (CVS)
(Delayed Data from NYSE)
$78.15 USD
+1.46 (1.90%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $78.00 -0.15 (-0.19%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, CVS Health Corporation has a PEG ratio of 0.79 compared to the Medical Services industry's PEG ratio of 1.67.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CVS 78.15 +1.46(1.90%)
Will CVS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for CVS
CVS Health (CVS) Reports Q3 Earnings: What Key Metrics Have to Say
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
Other News for CVS
Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus
Is CVS positioned for a breakout? 1,2,3 Pullback Bullish shows up after gaining 1.9%
Is CVS signaling a buying opportunity? Slingshot Bullish shows up after sliding 4.85%
Mizuho Securities Keeps Their Buy Rating on CVS Health (CVS)
My Top 10 High-Yield Picks For November 2025: One Yields 9%+